NDC Compounded Drug 73271-1012-1 Lidocaine; Tetracaine; Phenylephrine; Prilocaine

Gel Dental

Table of Contents

    1. Compounded Product Information
    2. Frequently Asked Questions

Compounded Drug Product Information

NDC Product Code 73271-1012
NDC Package Code 73271-1012-1
11-Digit NDC Billing Format NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.		 73271101201
Package Description 1 GEL in 1 JAR
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.		 Human Compounded Drug
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.		 Lidocaine/prilocaine/tetracaine/phenylephrine 10/10/4/2% 30 G Mint Flavor Dye Free
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.		 Lidocaine/prilocaine/tetracaine/phenylephrine 10/10/4/2% 30 G Mint Flavor Dye Free
Substance Name What is the Substance Name?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.		 Lidocaine; Tetracaine; Phenylephrine; Prilocaine
Dosage Form Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Route Name Dental - Administration to a tooth or teeth.
Marketing Category OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Code 73271
Labeler Name What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.		 Right Value Drug Stores Llc Dba Carie Boyd Pharmaceuticals
Substance Name Lidocaine; Tetracaine; Phenylephrine; Prilocaine
Active Ingredients Information .107 g; .04 g; .02 g; .1 g
Reporting Period 2023-2

Frequently Asked Questions

What is the NDC number assigned to Lidocaine/prilocaine/tetracaine/phenylephrine 10/10/4/2% 30 G Mint Flavor Dye Free?

Lidocaine/prilocaine/tetracaine/phenylephrine 10/10/4/2% 30 G Mint Flavor Dye Free was assigned by its manufacturer with NDC product code 73271-1012. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.

Which are the NDC package codes for Lidocaine/prilocaine/tetracaine/phenylephrine 10/10/4/2% 30 G Mint Flavor Dye Free?

The NDC package code 73271-1012-1 was assigned to a 1 GEL in 1 JAR of lidocaine; tetracaine; phenylephrine; prilocaine administered dental via gel.

Who manufactures this product?

Lidocaine/prilocaine/tetracaine/phenylephrine 10/10/4/2% 30 G Mint Flavor Dye Free is manufactured by an outsourced facility and labeled by Right Value Drug Stores Llc Dba Carie Boyd Pharmaceuticals. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.